Table of Content

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Market Definition and Overview
3. Executive Summary
3.1. Market Snippet by Application
3.2. Market Snippet by Region
4. Market Dynamics
4.1. Market Impacting Factors
4.2. Drivers
4.2.1. The high incidence rate of chronic diseases
4.2.2. Improved spending on healthcare
4.2.3. The rise in the availability of effective treatment methods
4.3. Restraints:
4.3.1. The high cost of organ transplant procedures
4.4. Opportunity
4.5. Impact Analysis
5. Industry Analysis
5.1. Porter’s Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Value Chain Analysis
5.4. PEST Analysis
5.5. Pricing Analysis
5.6. Regulatory Analysis
5.7. Reimbursement Analysis
5.8. Unmet Needs
5.9. Patent Trends
6. COVID-19 Analysis
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Application
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
7.1.2. Market Attractiveness Index, By Application Segment
7.2. Heart
7.2.1. Introduction
7.2.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
7.3. Liver
7.4. Lung
7.5. Kidney
7.6. Others
8. By Region
8.1. Introduction
8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
8.3. Market Attractiveness Index, By Region
8.4. North America
8.4.1. Introduction
8.4.2. Key Region-Specific Dynamics
8.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
8.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
8.4.4.1. The U.S.
8.4.4.2. Canada
8.4.4.3. Mexico
8.5. Europe
8.5.1. Introduction
8.5.2. Key Region-Specific Dynamics
8.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
8.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
8.5.4.1. Germany
8.5.4.2. The U.K.
8.5.4.3. France
8.5.4.4. Italy
8.5.4.5. Spain
8.5.4.6. Rest of Europe
8.6. South America
8.6.1. Introduction
8.6.2. Key Region-Specific Dynamics
8.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
8.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
8.6.4.1. Brazil
8.6.4.2. Argentina
8.6.4.3. Rest of South America
8.7. Asia Pacific
8.7.1. Introduction
8.7.2. Key Region-Specific Dynamics
8.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
8.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
8.7.4.1. China
8.7.4.2. India
8.7.4.3. Japan
8.7.4.4. Australia
8.7.4.5. Rest of Asia Pacific
8.8. The Middle East and Africa
8.8.1. Introduction
8.8.2. Key Region-Specific Dynamics
8.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
8.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9. Competitive Landscape
9.1. Competitive Scenario
9.2. Market Positioning/Share Analysis
9.3. Mergers and Acquisitions Analysis
10. Company Profiles
10.1. HIbernicor*
10.1.1. Company Overview
10.1.2. Product Portfolio and Description
10.1.3. Key Highlights
10.1.4. Financial Overview
10.2. OrganOx Limited
10.3. Institut Georges Lopez-IGL
10.4. Organ Recovery Systems, Inc.
10.5. Paragonix Technologies, Inc.
10.6. XVIVO Perfusion AB
10.7. Transmedics, Inc.
10.8. Other Companies
11. DataM Intelligence
11.1. Appendix
11.2. About Us and Services
11.3. Contact Us